Bruker Corporation
BRKR
Xếp hạng trong cổ phiếu
#2340
Bruker Corporation stands as a prominent global developer, manufacturer, and... Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
Giá cổ phiếu
$55.05
Vốn hóa thị trường
$8.39B
Thay đổi (1 ngày)
0.46%
Thay đổi (1 năm)
48.87%
Quốc gia
US
Giao dịch Bruker Corporation (BRKR)
Danh mục
Healthcare
Lịch sử cổ tức của Bruker Corporation (BRKR)
Bruker Corporation (mã cổ phiếu: BRKR) đã thực hiện tổng cộng 40 lần chi trả cổ tức.
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): $1.76
Tỷ suất cổ tức (TTM): 0.0036
Tổng tất cả cổ tức (đã điều chỉnh theo chia tách cổ phiếu): $1.76
Tỷ suất cổ tức (TTM): 0.0036
Các khoản chi trả cổ tức của Bruker Corporation (BRKR) từ 2016 đến 2026
Các khoản chi trả cổ tức hàng năm
| Năm | Cổ tức (đã điều chỉnh chia tách cổ phiếu) | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.05 | -75.00% |
| 2025 | $0.2 | 0.00% |
| 2024 | $0.2 | 0.00% |
| 2023 | $0.2 | 0.00% |
| 2022 | $0.2 | 25.00% |
| 2021 | $0.16 | 0.00% |
| 2020 | $0.16 | 0.00% |
| 2019 | $0.16 | 0.00% |
| 2018 | $0.16 | 0.00% |
| 2017 | $0.16 | 0.00% |
| 2016 | $0.16 | 0.00% |
Danh sách tất cả các khoản chi trả cổ tức
| Năm | Cổ tức | Thay đổi |
|---|---|---|
| 2026 (TTM) | $0.05 | -75.00% |
| 2025 | $0.2 | 0.00% |
| 2024 | $0.2 | 0.00% |
| 2023 | $0.2 | 0.00% |
| 2022 | $0.2 | 25.00% |
| 2021 | $0.16 | 0.00% |
| 2020 | $0.16 | 0.00% |
| 2019 | $0.16 | 0.00% |
| 2018 | $0.16 | 0.00% |
| 2017 | $0.16 | 0.00% |
| 2016 | $0.16 | 0.00% |
Cổ tức của các công ty tương tự hoặc đối thủ
| Công ty | Số lần chi trả cổ tức | Quốc gia |
|---|---|---|
| 173.00% |
US
|
|
| 178.00% |
IE
|
|
| 85.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
DE
|
